ITM11 expanded access program
Part of Brain & nervous system, Cancer clinical trials.
This is an expanded access program, also known as compassionate use, which allows patients with serious conditions to try an investigational drug when no other options are available. The trial tests a treatment called ITM11, but the specific details are not listed, so your doctor would need to contact the company for more information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your doctor) must ask about this program directly, because it is not listed on public registries.
- Your doctor must contact the sponsor, ITM Solucin GmbH, to request access for you.
- You must meet the program's internal criteria, which are not publicly listed but are reviewed on a case-by-case basis.
- You likely need to have a serious or life-threatening condition that has not responded to approved treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two oral drugs, IN10018 and dalpiciclib, for people with progressive meningioma (a type of brain tumor) that has not responded to standard treatments. The goal is to see if this combination can help shrink or slow the tumor.
This trial tests a new treatment for advanced brain cancers like glioma and meningioma. It combines your own immune cells (tumor-infiltrating lymphocytes or TILs) with an immunotherapy drug (pembrolizumab) to help your body fight the tumor. It's for people who have tried other treatments without success or have no standard options left.
This trial tests an experimental drug called IMC-001 for people whose cancer has spread or is locally advanced and has a high number of genetic mutations (TMB-H). The drug aims to help the immune system fight cancer.
This trial tests a new drug, SYHA1813, for people whose high-grade meningioma has come back or gotten worse after standard treatments like surgery and radiation. The goal is to see if this drug can help control the tumor and improve outcomes.
This trial tests an experimental drug called M1-c6v1 given through an IV for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it's safe and effective.
This Phase 1 study tests a new brain-tumor treatment in people with recurrent (coming back) high-grade glioma (brain cancer). The study uses injected medicine along with an implanted tumor device and aims to find whether the treatment is safe and can shrink or control tumors.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.